Related Articles
Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers
TPX2 is a prognostic marker and promotes cell proliferation in neuroblastoma
MYCN is amplified during S phase, and c‑myb is involved in controlling MYCN expression and amplification in MYCN‑amplified neuroblastoma cell lines
NCYM is upregulated by lncUSMycN and modulates N-Myc expression
Vascular endothelial growth factor blockade rapidly elicits alternative proangiogenic pathways in neuroblastoma